Maybe someone in Aus could give GK a call and ask if any light chain research is ongoing, and if the unknown drug is PBT2, does the hold statement apply. If PBT2 or another MPAC is effective in controlling say ,cardiomyopathy, even in a model, then that is very big news.
Phase1 may demonstrate target engagement, page-30
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
